"Plasminogen Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.
| Descriptor ID |
D010960
|
| MeSH Number(s) |
D08.811.277.656.300.760.635 D08.811.277.656.959.350.635 D12.776.124.125.662
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasminogen Activators".
Below are MeSH descriptors whose meaning is more specific than "Plasminogen Activators".
This graph shows the total number of publications written about "Plasminogen Activators" by people in this website by year, and whether "Plasminogen Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasminogen Activators" by people in Profiles.
-
Onteddu SR, Goddeau RP, Minaeian A, Henninger N. Clinical impact of leukoaraiosis burden and chronological age on neurological deficit recovery and 90-day outcome after minor ischemic stroke. J Neurol Sci. 2015 Dec 15; 359(1-2):418-23.
-
Bartra SS, Ding Y, Miya Fujimoto L, Ring JG, Jain V, Ram S, Marassi FM, Plano GV. Yersinia pestis uses the Ail outer membrane protein to recruit vitronectin. Microbiology (Reading). 2015 Nov; 161(11):2174-2183.
-
Eren E, Murphy M, Goguen J, van den Berg B. An active site water network in the plasminogen activator pla from Yersinia pestis. Structure. 2010 Jul 14; 18(7):809-18.
-
Wang S, Joshi S, Mboudjeka I, Liu F, Ling T, Goguen JD, Lu S. Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice. Vaccine. 2008 Mar 20; 26(13):1664-74.
-
Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). Prostate. 2004 May 01; 59(2):167-76.
-
Gates J, Hartnell GG. When urokinase was gone: commentary on another year of thrombolysis without urokinase. J Vasc Interv Radiol. 2004 Jan; 15(1 Pt 1):1-5.
-
Sungarian A, Duncan JA. Vertebrobasilar thrombosis in children: report of two cases and recommendations for treatment. Pediatr Neurosurg. 2003 Jan; 38(1):16-20.
-
M?ller-Hartmann W, Krings T, Mull M. [Hyperdense areal in the putamen after intra-arterial medialysis: contrast media extravasation or hemorrhage?]. Rofo. 2002 Apr; 174(4):497-8.
-
Hartnell GG, Gates J. The case of Abbokinase and the FDA: the events leading to the suspension of Abbokinase supplies in the United States. J Vasc Interv Radiol. 2000 Jul-Aug; 11(7):841-7.
-
Rosen MP, Sheiman R. Transhepatic mechanical thrombectomy followed by infusion of TPA into the superior mesenteric artery to treat acute mesenteric vein thrombosis. J Vasc Interv Radiol. 2000 Feb; 11(2 Pt 1):195-8.